Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1955 1
1956 1
1959 1
1960 1
1961 3
1962 3
1963 1
1965 1
1966 1
1967 1
1968 2
1969 3
1970 1
1974 3
1975 2
1977 1
1979 2
1981 2
1982 2
1984 4
1985 2
1986 2
1987 3
1988 6
1989 7
1990 1
1991 3
1992 3
1993 5
1994 4
1995 5
1996 7
1997 7
1998 4
1999 5
2000 4
2001 8
2002 5
2003 9
2004 4
2005 15
2006 11
2007 14
2008 16
2009 11
2010 10
2011 16
2012 15
2013 13
2014 18
2015 17
2016 19
2017 23
2018 10
2019 21
2020 18
2021 14
2022 26
2023 22
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

408 results

Results by year

Filters applied: . Clear all
Page 1
Warm winters are associated to more intense West Nile virus circulation in southern Spain.
Magallanes S, Llorente F, Ruiz-López MJ, Puente JM, Ferraguti M, Gutiérrez-López R, Soriguer R, Aguilera-Sepúlveda P, Fernández-Delgado R, Jímenez-Clavero MÁ, Figuerola J. Magallanes S, et al. Among authors: puente jm. Emerg Microbes Infect. 2024 Dec;13(1):2348510. doi: 10.1080/22221751.2024.2348510. Epub 2024 May 2. Emerg Microbes Infect. 2024. PMID: 38686545 Free PMC article.
Characterization of Responses to Lenvatinib plus Pembrolizumab in Patients with Advanced Renal Cell Carcinoma at the Final Prespecified Survival Analysis of the Phase 3 CLEAR Study.
Motzer RJ, Choueiri TK, Hutson T, Young Rha S, Puente J, Lalani AA, Winquist E, Eto M, Basappa NS, Tannir NM, Vaishampayan U, Bjarnason GA, Oudard S, Grünwald V, Burgents J, Xie R, McKenzie J, Powles T. Motzer RJ, et al. Among authors: puente j. Eur Urol. 2024 Apr 5:S0302-2838(24)02234-6. doi: 10.1016/j.eururo.2024.03.015. Online ahead of print. Eur Urol. 2024. PMID: 38582713 Free article.
CRISPR/Cas9 screenings unearth protein arginine methyltransferase 7 as a novel essential gene in prostate cancer metastasis.
Rodrigo-Faus M, Vincelle-Nieto A, Vidal N, Puente J, Saiz-Pardo M, Lopez-Garcia A, Mendiburu-Eliçabe M, Palao N, Baquero C, Linzoain-Agos P, Cuesta AM, Qu HQ, Hakonarson H, Musteanu M, Reyes-Palomares A, Porras A, Bragado P, Gutierrez-Uzquiza A. Rodrigo-Faus M, et al. Among authors: puente j. Cancer Lett. 2024 Apr 28;588:216776. doi: 10.1016/j.canlet.2024.216776. Epub 2024 Mar 2. Cancer Lett. 2024. PMID: 38432581 Free article.
Criteria and indicators to evaluate quality of care in genitourinary tumour boards.
Puente J, Algaba Arrea F, Buisán Rueda Ó, Castellano Gauna D, Durán I, Fernández Ávila JJ, Gómez-Iturriaga A, Parada Blázquez MJ, Pérez Fentes D, Sancho Pardo G, Vallejo Casas JA, Gratal P, Pardo MT, Guillem Porta V. Puente J, et al. Clin Transl Oncol. 2024 Feb 11. doi: 10.1007/s12094-024-03381-z. Online ahead of print. Clin Transl Oncol. 2024. PMID: 38341809
Exploratory analyses of treatment subgroup interaction by PD-L1 status and according to PD-L1 expression in the JAVELIN Bladder 100 trial.
Climent MÁ, Álvarez C, Morales R, Maroto P, Rodríguez-Vida A, Méndez-Vidal MJ, Del Muro XG, Puente J, Láinez N, Vázquez S, Castellano D, Lang CG, Wang J, di Pietro A, Davis C, Sanz-Castillo B, Bolós MV, Valderrama BP. Climent MÁ, et al. Among authors: puente j. Clin Transl Oncol. 2023 Dec 15. doi: 10.1007/s12094-023-03358-4. Online ahead of print. Clin Transl Oncol. 2023. PMID: 38102374
Phase II trial of afatinib in patients with advanced urothelial carcinoma with genetic alterations in ERBB1-3 (LUX-Bladder 1).
Font A, Mellado B, Climent MA, Virizuela JA, Oudard S, Puente J, Castellano D, González-Del-Alba A, Pinto A, Morales-Barrera R, Rodriguez-Vida A, Fernandez PL, Teixido C, Jares P, Aldecoa I, Gibson N, Solca F, Mondal S, Lorence RM, Serra J, Real FX. Font A, et al. Among authors: puente j. Br J Cancer. 2024 Feb;130(3):434-441. doi: 10.1038/s41416-023-02513-6. Epub 2023 Dec 15. Br J Cancer. 2024. PMID: 38102226 Clinical Trial.
Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study.
Grande E, Arranz JÁ, De Santis M, Bamias A, Kikuchi E, Del Muro XG, Park SH, De Giorgi U, Alekseev B, Mencinger M, Izumi K, Schutz FA, Puente J, Li JR, O'Donnell PH, Kalebasty AR, Ye D, Mariathasan S, Bene-Tchaleu F, Bernhard S, Lee C, Davis ID, Galsky MD. Grande E, et al. Among authors: puente j. Lancet Oncol. 2024 Jan;25(1):29-45. doi: 10.1016/S1470-2045(23)00540-5. Epub 2023 Dec 12. Lancet Oncol. 2024. PMID: 38101433 Clinical Trial.
408 results